Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank79
3Y CAGR+14.7%
5Y CAGR+1.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+14.7%/yr
vs -12.0%/yr prior
5Y CAGR
+1.9%/yr
Recent acceleration
Acceleration
+26.7pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $93.03M | +58.9% |
| 2024 | $58.53M | +0.6% |
| 2023 | $58.18M | -5.7% |
| 2022 | $61.69M | -62.8% |
| 2021 | $165.75M | +95.5% |
| 2020 | $84.77M | +35.8% |
| 2019 | $62.44M | -39.3% |
| 2018 | $102.87M | +3.5% |
| 2017 | $99.39M | +142.4% |
| 2016 | $41.00M | - |